Atlas Trials

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Clinical trial NCT00074971 · COMPLETED

Trial details

NCT number
NCT00074971
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Fabry Disease
Start date
1999-10-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.